BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22231783)

  • 1. Ablation of ceramide synthase 2 strongly affects biophysical properties of membranes.
    Silva LC; Ben David O; Pewzner-Jung Y; Laviad EL; Stiban J; Bandyopadhyay S; Merrill AH; Prieto M; Futerman AH
    J Lipid Res; 2012 Mar; 53(3):430-436. PubMed ID: 22231783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical role for ceramide synthase 2 in liver homeostasis: I. alterations in lipid metabolic pathways.
    Pewzner-Jung Y; Park H; Laviad EL; Silva LC; Lahiri S; Stiban J; Erez-Roman R; Brügger B; Sachsenheimer T; Wieland F; Prieto M; Merrill AH; Futerman AH
    J Biol Chem; 2010 Apr; 285(14):10902-10. PubMed ID: 20110363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablation of very long acyl chain sphingolipids causes hepatic insulin resistance in mice due to altered detergent-resistant membranes.
    Park JW; Park WJ; Kuperman Y; Boura-Halfon S; Pewzner-Jung Y; Futerman AH
    Hepatology; 2013 Feb; 57(2):525-32. PubMed ID: 22911490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in membrane biophysical properties induced by sphingomyelinase depend on the sphingolipid N-acyl chain.
    Pinto SN; Laviad EL; Stiban J; Kelly SL; Merrill AH; Prieto M; Futerman AH; Silva LC
    J Lipid Res; 2014 Jan; 55(1):53-61. PubMed ID: 24163422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablation of ceramide synthase 2 causes chronic oxidative stress due to disruption of the mitochondrial respiratory chain.
    Zigdon H; Kogot-Levin A; Park JW; Goldschmidt R; Kelly S; Merrill AH; Scherz A; Pewzner-Jung Y; Saada A; Futerman AH
    J Biol Chem; 2013 Feb; 288(7):4947-56. PubMed ID: 23283968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult ceramide synthase 2 (CERS2)-deficient mice exhibit myelin sheath defects, cerebellar degeneration, and hepatocarcinomas.
    Imgrund S; Hartmann D; Farwanah H; Eckhardt M; Sandhoff R; Degen J; Gieselmann V; Sandhoff K; Willecke K
    J Biol Chem; 2009 Nov; 284(48):33549-60. PubMed ID: 19801672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective ceramide synthases in mice cause reduced amplitudes in electroretinograms and altered sphingolipid composition in retina and cornea.
    Brüggen B; Kremser C; Bickert A; Ebel P; Vom Dorp K; Schultz K; Dörmann P; Willecke K; Dedek K
    Eur J Neurosci; 2016 Jul; 44(1):1700-13. PubMed ID: 27086873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic fatty acid uptake is regulated by the sphingolipid acyl chain length.
    Park WJ; Park JW; Merrill AH; Storch J; Pewzner-Jung Y; Futerman AH
    Biochim Biophys Acta; 2014 Dec; 1841(12):1754-66. PubMed ID: 25241943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altering sphingolipid composition with aging induces contractile dysfunction of gastric smooth muscle via K(Ca) 1.1 upregulation.
    Choi S; Kim JA; Kim TH; Li HY; Shin KO; Lee YM; Oh S; Pewzner-Jung Y; Futerman AH; Suh SH
    Aging Cell; 2015 Dec; 14(6):982-94. PubMed ID: 26288989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress elicited by modifying the ceramide acyl chain length reduces the rate of clathrin-mediated endocytosis.
    Volpert G; Ben-Dor S; Tarcic O; Duan J; Saada A; Merrill AH; Pewzner-Jung Y; Futerman AH
    J Cell Sci; 2017 Apr; 130(8):1486-1493. PubMed ID: 28280117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eleven residues determine the acyl chain specificity of ceramide synthases.
    Tidhar R; Zelnik ID; Volpert G; Ben-Dor S; Kelly S; Merrill AH; Futerman AH
    J Biol Chem; 2018 Jun; 293(25):9912-9921. PubMed ID: 29632068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of a ceramide synthase 2 null mouse from drug-induced liver injury: role of gap junction dysfunction and connexin 32 mislocalization.
    Park WJ; Park JW; Erez-Roman R; Kogot-Levin A; Bame JR; Tirosh B; Saada A; Merrill AH; Pewzner-Jung Y; Futerman AH
    J Biol Chem; 2013 Oct; 288(43):30904-16. PubMed ID: 24019516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical role for ceramide synthase 2 in liver homeostasis: II. insights into molecular changes leading to hepatopathy.
    Pewzner-Jung Y; Brenner O; Braun S; Laviad EL; Ben-Dor S; Feldmesser E; Horn-Saban S; Amann-Zalcenstein D; Raanan C; Berkutzki T; Erez-Roman R; Ben-David O; Levy M; Holzman D; Park H; Nyska A; Merrill AH; Futerman AH
    J Biol Chem; 2010 Apr; 285(14):10911-23. PubMed ID: 20110366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid domain formation and membrane shaping by C24-ceramide.
    Ventura AE; Varela ARP; Dingjan T; Santos TCB; Fedorov A; Futerman AH; Prieto M; Silva LC
    Biochim Biophys Acta Biomembr; 2020 Oct; 1862(10):183400. PubMed ID: 32565121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Widespread tissue distribution and synthetic pathway of polyunsaturated C24:2 sphingolipids in mammals.
    Edagawa M; Sawai M; Ohno Y; Kihara A
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Dec; 1863(12):1441-1448. PubMed ID: 30251650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceramide: a simple sphingolipid with unique biophysical properties.
    Castro BM; Prieto M; Silva LC
    Prog Lipid Res; 2014 Apr; 54():53-67. PubMed ID: 24513486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altering the sphingolipid acyl chain composition prevents LPS/GLN-mediated hepatic failure in mice by disrupting TNFR1 internalization.
    Ali M; Fritsch J; Zigdon H; Pewzner-Jung Y; Schütze S; Futerman AH
    Cell Death Dis; 2013 Nov; 4(11):e929. PubMed ID: 24263103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceramide Synthase 2 Null Mice Are Protected from Ovalbumin-Induced Asthma with Higher T Cell Receptor Signal Strength in CD4+ T Cells.
    Shin SH; Cho KA; Yoon HS; Kim SY; Kim HY; Pewzner-Jung Y; Jung SA; Park WJ; Futerman AH; Park JW
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Intracellular Lipid Logistics in the Preferential Usage of Very Long Chain-Ceramides in Glucosylceramide.
    Yamaji T; Horie A; Tachida Y; Sakuma C; Suzuki Y; Kushi Y; Hanada K
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate.
    Laviad EL; Albee L; Pankova-Kholmyansky I; Epstein S; Park H; Merrill AH; Futerman AH
    J Biol Chem; 2008 Feb; 283(9):5677-84. PubMed ID: 18165233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.